Form 4 for NVCT Nuvectis Pharma, Inc.
Accepted 2026-08-05 17:26:08 ET · period of report 2026-08-03 · accession 0001104659-26-091279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 17:26 | 2026-08-03 | NVCT | Carson Michael J. | VP, Fin | A - Grant | $0.00 | +30.0K | 230.1K | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-03 | A | A | 30,000 | $0.00 | 230,118 | D | — | — | (F1) The 30,000 shares of restricted common stock will fully vest on August 3, 2027, subject to Mr. Carson's continued service on such date. (F2) Includes shares of restricted common stock. |